Secondary dyslipidemia: its treatments and association with atherosclerosis
H Yanai, H Yoshida - Global health & medicine, 2021 - jstage.jst.go.jp
Dyslipidemia is classified into primary and secondary types. Primary dyslipidemia is
basically inherited and caused by single or multiple gene mutations that result in either …
basically inherited and caused by single or multiple gene mutations that result in either …
A critical review of the biochemical mechanisms and epigenetic modifications in HIV-and antiretroviral-induced metabolic syndrome
Metabolic syndrome (MetS) is a non-communicable disease characterised by a cluster of
metabolic irregularities. Alarmingly, the prevalence of MetS in people living with Human …
metabolic irregularities. Alarmingly, the prevalence of MetS in people living with Human …
Japan Atherosclerosis Society (JAS) Guidelines for prevention of atherosclerotic cardiovascular diseases 2022
T Okamura, K Tsukamoto, H Arai, Y Fujioka… - … of Atherosclerosis and …, 2024 - jstage.jst.go.jp
In Japan, a super-aged society, deaths from atherosclerotic cardiovascular disease
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …
(ASCVD), especially cardiac diseases including coronary artery disease (CAD) such as …
Blood glucose trajectories and incidence of diabetes mellitus in Ugandan people living with HIV initiated on dolutegravir
F Mulindwa, B Castelnuovo, N Brusselaers… - AIDS research and …, 2023 - Springer
Background Following reports of anti-retroviral therapy (ART) experienced Ugandan people
living with HIV (PLHIV) presenting with diabetic ketoacidosis weeks to months following a …
living with HIV (PLHIV) presenting with diabetic ketoacidosis weeks to months following a …
Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection
Chronic Human Immunodeficiency Virus (HIV) infection remains a significant challenge to
global public health. Despite advances in antiretroviral therapy (ART), which has …
global public health. Despite advances in antiretroviral therapy (ART), which has …
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda
Background Combined antiretroviral therapy (cART) dramatically improved survival in
people living with HIV (PLWH) but is associated with weight gain (WG), raising concern for a …
people living with HIV (PLWH) but is associated with weight gain (WG), raising concern for a …
Mechanisms of immune aging in HIV
M Chauvin, D Sauce - Clinical Science, 2022 - portlandpress.com
Massive CD4+ T-cell depletion as well as sustained immune activation and inflammation are
hallmarks of Human Immunodeficiency Virus (HIV)-1 infection. In recent years, an emerging …
hallmarks of Human Immunodeficiency Virus (HIV)-1 infection. In recent years, an emerging …
Patient experience evaluation of the CMO-based pharmaceutical care model vs usual care in people living with HIV
R Morillo-Verdugo, A Lazaro-Lopez… - Journal of …, 2022 - Taylor & Francis
Objective To compare patient experience in a real-life population of people living with HIV
(PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation …
(PLWH) who received pharmaceutical care (PC) based on the Capacity-Motivation …
Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: a systematic review and …
F Mulindwa, H Kamal, B Castelnuovo… - BMJ Open Diabetes …, 2023 - drc.bmj.com
Whether integrase strand transfer inhibitors (INSTIs) are associated with a higher risk of
incident type 2 diabetes mellitus (DM) than other antiretroviral therapies (ART) needs to be …
incident type 2 diabetes mellitus (DM) than other antiretroviral therapies (ART) needs to be …
Dyslipidemia and Nutritional Status of HIV-Infected Children and Adolescents on Antiretroviral Treatment at the Comprehensive Chronic Care and Training Center of …
T Ambisa Lamesa, A Getachew Mamo… - HIV/AIDS-Research …, 2023 - Taylor & Francis
Background Highly active antiretroviral treatment is beneficial to suppress human immune
virus replication in infected individuals. However, dyslipidemia and other metabolic …
virus replication in infected individuals. However, dyslipidemia and other metabolic …